CN110975163B - Portable graphene far infrared mammary gland hyperplasia therapeutic apparatus - Google Patents
Portable graphene far infrared mammary gland hyperplasia therapeutic apparatus Download PDFInfo
- Publication number
- CN110975163B CN110975163B CN201911306481.8A CN201911306481A CN110975163B CN 110975163 B CN110975163 B CN 110975163B CN 201911306481 A CN201911306481 A CN 201911306481A CN 110975163 B CN110975163 B CN 110975163B
- Authority
- CN
- China
- Prior art keywords
- temperature detector
- far infrared
- electrode
- lead
- controller
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title claims abstract description 53
- 229910021389 graphene Inorganic materials 0.000 title claims abstract description 45
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 45
- 206010020718 hyperplasia Diseases 0.000 title claims abstract description 23
- 210000005075 mammary gland Anatomy 0.000 title claims abstract description 21
- 238000009413 insulation Methods 0.000 claims abstract 3
- 239000010410 layer Substances 0.000 claims description 21
- 238000002560 therapeutic procedure Methods 0.000 claims description 8
- 239000000523 sample Substances 0.000 claims description 6
- 239000000017 hydrogel Substances 0.000 claims description 5
- 239000011241 protective layer Substances 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical group [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 claims description 2
- 239000012790 adhesive layer Substances 0.000 claims description 2
- 229910001416 lithium ion Inorganic materials 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 abstract description 2
- 239000000499 gel Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 238000004891 communication Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000002041 carbon nanotube Substances 0.000 description 4
- 229910021393 carbon nanotube Inorganic materials 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 239000002086 nanomaterial Substances 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 229920002379 silicone rubber Polymers 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000008054 signal transmission Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- HBUBKKRHXORPQB-UHFFFAOYSA-N 2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1C1OC(CO)C(O)C1O HBUBKKRHXORPQB-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010006272 Breast mass Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 description 1
- 229960002802 bromocriptine Drugs 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- POZRVZJJTULAOH-LHZXLZLDSA-N danazol Chemical compound C1[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=CC2=C1C=NO2 POZRVZJJTULAOH-LHZXLZLDSA-N 0.000 description 1
- 229960000766 danazol Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- -1 graphite alkene Chemical class 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Abstract
The invention discloses a portable graphene far-infrared mammary gland hyperplasia therapeutic apparatus. The therapeutic instrument includes controller and treatment head group, the controller is connected treatment head group, treatment head group includes 1 above treatment head, the treatment head includes heat conduction insulation layer (3), far infrared emission source (2) and tie coat (5), far infrared emission source (2) are located inside heat conduction insulation layer (3), tie coat (5) are located the bottom surface of treatment head. The invention can realize the output of multiple treatment heads and the independent control of the breast therapeutic apparatus, and can realize the simultaneous treatment of the hyperplasia of mammary glands at different parts.
Description
Technical Field
The invention relates to the field of medical instruments, in particular to a portable graphene far-infrared mammary gland hyperplasia therapeutic apparatus.
Background
Hyperplasia of mammary glands is a non-neoplastic and non-inflammatory disorder of the breast that is characterized clinically primarily by breast lumps and breast pain, which usually worsen during the premenstrual phase and lessen after menstruation. A small proportion of the hyperplasia of mammary glands has the potential to develop into breast cancer.
The pathogenesis of hyperplasia of mammary glands is unclear, and mental stimulation is mostly considered to change the internal environment of a human body, so that the function of an endocrine system is influenced, and the secretion of one or more hormones is abnormal. The poor mental factors such as over-stress and over-excited emotion can cause that the hyperplasia of mammary glands which should be restored originally can not be restored or can not be restored completely, and hyperplasia of mammary glands is formed after a long time.
The manifestations of cyclomastopathy are mainly divided into three aspects: one is cystic expansion of the mammary duct, forming cysts of different sizes and quantities; secondly, mammary duct epithelium shows hyperplasia of different degrees; the third is the hyperplasia of fibrous tissue in and between the lobules of the mammary gland.
At the present stage, there is no definite or specific treatment method for hyperplasia of mammary glands, and clinically, the main treatment methods include: (1) change bad living habits, relax mood and release stress. (2) And (5) treating with western medicines. The western medicines danazol, tamoxifen and bromocriptine are effective medicines for treating hyperplasia of mammary glands, but have relatively large adverse reactions. (3) Treating with Chinese medicinal materials. Most of the Chinese mammary gland hyperplasia patients are treated by the traditional Chinese medicine. In treatment, the treatment principle is qi circulation promoting, blood circulation promoting, hardness softening and stagnation dissipating. However, oral traditional Chinese medicine treatment has the defects of long treatment period, difficult oral administration, difficult long-term adherence, slow effect and the like. (4) And (5) surgical treatment. General hyperplasia does not have operative indications, and the main purpose is to avoid missing, misdiagnosing breast cancer, or excising suspicious lesions. And the operation affects the beauty and is not accepted and accepted by the patients. (5) And (4) physical therapy. In recent years, acupuncture, moxibustion, far infrared and other treatment methods are adopted, and the curative effect is better. However, these methods of acupuncture and moxibustion lack uniform operating criteria and require specialized personnel to perform the treatment. The current used far infrared equipment is too large in size and inconvenient to use; or is often associated with drugs, presenting a risk of drug allergy.
The far infrared ray has strong penetrating power and radiation power, has obvious temperature control effect and resonance effect, and is easy to be absorbed by object and converted into internal energy of object. After the far infrared rays are absorbed by human bodies, water molecules in the bodies can resonate, so that the water molecules are activated, the binding force among other molecules is enhanced, and therefore, biological macromolecules such as proteins and the like are activated, and the cells of the organisms are at the highest vibration energy level. Because the biological cells generate resonance effect, the far infrared heat energy can be transmitted to the deeper part of the human skin, so that the temperature of the deep layer is raised, and the generated heat is emitted from inside to outside. The effects of dilating blood capillary, promoting blood circulation, enhancing metabolism of tissues, promoting tissue regeneration, enhancing immunity, and regulating mental abnormal excitation state are achieved.
Graphene is a novel nano-material,is a two-dimensional layered single carbon with single atom thickness, and is formed by sp2The hybridized carbon atoms are orderly arranged on a two-dimensional plane. The unique structure endows the graphene with excellent electrical, optical, mechanical and thermal properties, is the thinnest novel nano material with the maximum strength and the strongest electric and heat conduction performance which is discovered at present, and the electric conduction performance is higher than that of a common conductive medium by 80 percent. The graphene heating film is one hundred percent of carbon, and the generated far infrared radiation has good medical physiotherapy effect. The wavelength of far infrared rays of graphene is 6-14 mu m, and an infrared spectrogram generated by the graphene heating film and an infrared spectrogram of a human body have similar spectrogram characteristics in a far infrared ray wavelength range. The far infrared energy peak of graphene is about 9 μm, which can cause human body resonance, and is called "light of life" in the scientific community.
Disclosure of Invention
The technical problem to be solved by the invention is as follows: the existing treatment means cannot be well applied and popularized due to the characteristics of professional treatment mode or large volume of treatment equipment and the like. Therefore, it is very urgent and important to provide a portable therapeutic apparatus for treating hyperplasia of mammary glands, which can treat multiple parts simultaneously.
The invention provides a portable mammary gland hyperplasia therapeutic apparatus capable of realizing multipoint independent temperature control therapy.
Specifically, the invention provides the following technical scheme:
the invention provides a far infrared mammary gland hyperplasia therapeutic apparatus, which comprises a controller 1 and a therapeutic head group, wherein the controller is connected with the therapeutic head group, the therapeutic head group comprises more than 1 therapeutic head, the therapeutic head comprises a heat conduction insulating layer 3, a far infrared emission source 2 and a bonding layer 5, the far infrared emission source 2 is positioned in the heat conduction insulating layer 3, the bonding layer 5 is positioned on the bottom surface of the therapeutic head, and preferably, the therapeutic head group comprises more than 2 therapeutic heads which are independent or connected into a whole.
Preferably, in the above therapeutic apparatus, the far infrared emission source 2 includes a transparent graphene electrothermal film and a temperature detector 4, the transparent graphene electrothermal film includes an insulating protective layer, graphene and an electrode disposed on the surface of the graphene; preferably, the temperature detection is carried out, and a probe of 4 is contacted with the transparent graphene electrothermal film;
more preferably, said temperature probe 4 comprises a first and a second terminal pin, said electrodes comprise a first and a second pole 9, 10; a first wiring pin of the temperature detector 4 is connected with a first pole 9 of the electrode, and a second wiring pin of the temperature detector 4 is not connected with the electrode;
more preferably, the number of layers of the graphene is 1-5.
Preferably, the above therapeutic apparatus, wherein the far infrared emission source 2 comprises a conducting wire 8, the conducting wire 8 comprises a first conducting wire, a second conducting wire and a third conducting wire, the first conducting wire is connected with the first connection pin of the temperature detector 4 and/or the first pole 9 of the electrode, the second conducting wire is connected with the second connection pin of the temperature detector 4, and the third conducting wire is connected with the second pole 10 of the electrode;
preferably, a first wiring pin of the temperature detector 4 is provided with a first conductive terminal 11, a second wiring pin of the temperature detector 4 is provided with a second conductive terminal 12, a first pole 9 of the electrode and the temperature detector 4 share the first conductive terminal 11, a second pole 10 of the electrode is provided with a third conductive terminal 13, the first conducting wire is connected with the first conductive terminal 11, the second conducting wire is connected with the second conductive terminal 12, and the third conducting wire is connected with the third conductive terminal 13.
Preferably, the above therapeutic apparatus, wherein the heat conducting and insulating layer 3 is selected from transparent soft materials, preferably, the heat conducting and insulating layer 3 is selected from transparent silicone gel; more preferably, the adhesive layer 5 is selected from hydrogels.
Preferably, the therapeutic apparatus is a fan-shaped therapeutic apparatus.
Preferably, the above mentioned therapeutic apparatus, wherein the controller 1 is provided with a power supply inside; preferably, the power source is selected from lithium ion batteries.
Preferably, the above mentioned therapeutic apparatus, wherein said controller 1 comprises a control system, said control system comprising an MCU unit;
preferably, the control system comprises a power management unit and a temperature control unit; more preferably, the power management unit controls the voltage and/or current output by the power supply, and more preferably, the temperature control unit is connected with a temperature detector 4 on the far infrared emission source 2.
Preferably, the above therapeutic apparatus, wherein the control system further comprises an input unit, an output unit, a communication interface unit and/or a power consumption management unit.
Preferably, the above therapeutic apparatus, wherein the controller 1 and the therapeutic head set are connected by an elastic wire, preferably, the elastic wire is selected from carbon nanotube composite materials.
Preferably, the above therapeutic apparatus, wherein the controller is provided with a reel inside.
The beneficial effects of the invention include:
1. the invention adopts a plurality of treatment heads, and can realize simultaneous treatment on hyperplasia of mammary glands of a plurality of different parts.
2. The connecting line of the invention can realize small-range adjustment to meet the requirements of different treatment lengths.
3. The invention adopts the treatment head group with a plurality of treatment heads, and has portability compared with the prior equipment.
4. The invention adopts the battery for power supply, is directly worn on the human body and is convenient for movement.
Drawings
FIG. 1 is a schematic view of the apparatus of example 1;
fig. 2 is a schematic diagram of a control system in embodiment 1, including: the device comprises an input unit, an output unit, an MCU unit, a communication interface unit, a power management unit, a power consumption management unit and a temperature control unit;
FIG. 3 is a schematic view of a treatment head 21 according to example 1;
FIG. 4 is a schematic view of a far infrared emission source in example 1;
FIG. 5 is a schematic view of the apparatus according to example 2;
in the figure, 1-control system, 2-far infrared emission source, 3-silicon gel, 4-temperature detector, 5-hydrogel bonding layer, 6-reinforcing sleeve, 7-thickened part, 8-lead, 9-first pole of electrode, 10-second pole of electrode, 11-first conductive terminal, 12-second conductive terminal, 13-third conductive terminal, 21, 22, 23-treatment head.
Detailed Description
The technical scheme of the invention is clearly and completely described in the following with reference to the accompanying drawings. Obviously, all other embodiments obtained by a person skilled in the art without making creative efforts based on the specific embodiments of the present invention belong to the protection scope of the present invention.
It is noted that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of exemplary embodiments according to the invention.
In the description of the present invention, unless otherwise expressly specified or limited, the terms "mounted," "connected," and "connected" are to be construed broadly, e.g., as meaning a fixed connection, a removable connection, or an integral connection; they may be connected directly or indirectly through intervening media, or they may be interconnected between two elements. The specific meanings of the above terms in the present invention can be understood in specific cases to those skilled in the art.
Unless otherwise specified, terms such as "upper," "lower," "inner," "outer," and the like, refer to an orientation or positional relationship based on that shown in the drawings, which is for convenience in describing the present invention and simplifying the description, and do not indicate or imply that the referenced device or element must have a particular orientation, be constructed and operated in a particular orientation, and thus should not be construed as limiting the present invention.
The terms "first", "second" and "third" are used for descriptive purposes only and are not to be construed as being of relative importance.
The term "MCU Unit" refers to a Micro Controller Unit (MCU), which is also called a Single Chip Microcomputer (Single Chip Microcomputer) or a Single Chip Microcomputer.
The term "graphene" or "single-layer graphene" refers to only one layer of carbon atoms in sp2The hybrid tracks form a hexagonal honeycomb-shaped two-dimensional carbon nanomaterial comprising doped or undoped graphene.
The silicone gel is one of addition type silicone rubbers, is a hardness ultra-soft silicone rubber, is environment-friendly, nontoxic and tasteless, and is an addition type silicone rubber which is more and more extensive in application field. Jelly is also called because it is as soft as jelly after solidification.
The invention aims to provide a portable hyperplasia of mammary glands therapeutic apparatus, and in a preferable scheme of the invention, the hyperplasia of mammary glands therapeutic apparatus consists of a controller, a therapeutic head group and connecting lines between the controller and the therapeutic head group.
In a preferred scheme of the invention, the controller comprises a control system, wherein the control system comprises an input unit, an output unit, a communication interface unit, a power management unit, a power consumption management unit, a temperature control unit and an MCU unit, and the control system is used for completing the functions of receiving input signals, controlling temperature, adjusting gears, outputting indication and the like.
In a preferred embodiment of the present invention, the input unit is a key input unit, and includes a key signal input for turning on and off, a signal input for adjusting a gear, a signal input for operating mode, and the like. Alternatively, the control input unit may also adopt a voice input mode.
In a preferred embodiment of the present invention, the output unit is an indicator light display unit, which includes an electric quantity indicator light display, a working state indicator light display, and the like. Alternatively, the output unit may be a screen display, and the related display may also be completed through APP (Application).
In a preferred scheme of the invention, the communication interface unit comprises a Bluetooth interface, a serial port and the like. The Bluetooth interface is used for voice input, APP connection and other functions. The serial port is used for debugging and the like.
In the preferred scheme of the invention, the power supply management unit mainly completes the charge and discharge control of the power supply and the monitoring of the electric quantity, generates an alarm signal when the electric quantity is low, reports the alarm signal to the MCU unit, and outputs an indication by the MCU unit. The invention adopts the lithium battery for power supply, and is safe and portable. The charging port of the lithium battery adopts a universal Mini USB interface.
In the preferable scheme of the invention, the power consumption management unit adopts a Pulse Width Modulation (PWM) control mode to control the working time periods of different treatment heads in a time-sharing manner, so that the power consumption peak value of the system is reduced, and the requirement of controlling the temperature is met.
In the preferred scheme of the invention, the temperature control unit mainly collects and manages the temperature information collected by an ntc (negative temperature coefficient) thermistor embedded in the treatment head 2, and the temperature information is fed back to the MCU unit, so as to control the working voltage and current of the treatment head.
In the preferred scheme of the invention, the MCU unit realizes the storage, processing and transmission of related data. The MCU sets relevant working states including working temperature, working duration, working area and the like according to input data of the input unit, and then feeds back the working states to the temperature control unit, the output unit, the power management unit and the power consumption management unit.
In a preferred scheme of the invention, the treatment head group comprises N (N is more than or equal to 1) independent small treatment heads, realizes the treatment of different areas, and is respectively connected with the control system through a connecting line, as shown in fig. 3. Alternatively, the treatment head can be made into an integral treatment head but comprises N (N ≧ 1) subareas, each of which can be independently temperature controlled, as shown in FIG. 4. The integrated therapy device has the advantages that the wearing is more convenient, but the adaptability of the therapy part is not good than that of independent multiple small therapy heads.
In the preferred scheme of the invention, the therapeutic head adopts a mode of embedding the far infrared emission source in the medical silica gel, so that the flexibility and the comfort degree of the therapeutic head are improved. The medical gel is arranged on one side of the treatment head, which is attached to the skin, so that the treatment head can be well attached to the skin.
In a preferred scheme of the invention, the far infrared emission source comprises a transparent graphene electrothermal film and a temperature detector, the transparent graphene electrothermal film comprises an insulating protective layer, graphene and an electrode arranged on the surface of the graphene, and a probe of the temperature detector is connected with the transparent graphene electrothermal film.
The transparent graphene electrothermal film takes large-size graphene as a heating layer. Generally, only graphene with larger size (e.g. 2cm × 2cm, 10cm × 20cm) is used as a heat generating material to produce a transparent graphene electrothermal film, while graphene micro-sheets with small size (e.g. millimeter or micron size) formed by stacking have low light transmittance, and generally can only be used as a black film. Through adjusting the number of graphene layers in the graphene electrothermal film, the resistance of the graphene electrothermal film can be changed, and therefore the heating power can be adjusted.
Alternatively, the large-size graphene can be prepared by a chemical vapor deposition method, and the transparent graphene electrothermal film can be prepared by a method of CN 105517215B.
In the preferred scheme of the invention, after the far infrared emission source is communicated with the power supply, each component distinguishes a positive electrode and a negative electrode, wherein the part connected with the positive electrode of the power supply is the positive electrode, and the part connected with the negative electrode of the power supply is the negative electrode. The negative pole wiring foot of temperature detector sets up the negative terminal, temperature detector's positive pole wiring foot sets up first positive terminal, the negative pole of electrode with a negative terminal of temperature detector sharing, the positive pole of electrode sets up the second positive terminal, and negative pole wire is connected to the negative terminal, and positive wire is connected to the positive terminal. The terminal is the conductor, fixes wire, temperature detector and transparent graphite alkene electric heat membrane together, has both guaranteed the power supply of diaphragm, has satisfied the transmission of temperature detector signal of telecommunication again, has solved temperature detector's fixed problem simultaneously again.
The connecting line 3 between the controller and the therapy head realizes the transmission of signals and the power supply. In order to adapt to the distances between different treatment areas and a control system, the connecting wire is made of a wire with elasticity, such as a wire made of a rubber composite carbon nanotube material, and the length of the connecting wire can be adjusted within a small range (<15cm) without influencing signal transmission and power supply. Optionally, the length of the connecting line can be controlled by a micro-reel built in the controller, and the distance between the controller and the treatment head can be adjusted according to the use requirement. The problem that the common lead is adopted, the length cannot adapt to all treatment scenes, or the wearing discomfort caused by the redundant length of the lead is avoided.
Example 1
As shown in figure 1, the therapeutic apparatus of the embodiment comprises a controller 1, a treatment head 21 and a treatment head 22 which are in a fan-ring shape, and the controller and the treatment head are connected through an elastic lead 8 made of a rubber composite carbon nanotube material. The controller 1 includes a control system, as shown in fig. 2, the control system includes an input unit, an output unit, a communication interface unit, a power management unit, a power consumption management unit, a temperature control unit, and an MCU unit, and completes functions of receiving an input signal, controlling temperature, adjusting a gear, outputting an instruction, and the like. As shown in fig. 3, the treatment head 21 comprises a far infrared emission source 2, a heat-conducting insulating transparent silicon gel 3 and a hydrogel bonding layer 5. The far infrared emission source 2 is located inside the silicone gel 3, the far infrared emission source 2 comprises an elastic lead 8, the elastic lead 8 penetrates out from one end of the silicone gel 3, and the hydrogel bonding layer 5 is located on the bottom surface of the electric heating patch. The connection part of the lead 8 and the silicone gel 3 is provided with a reinforcing sleeve 6, and one side of the silicone gel 3 connected with the lead 8 is provided with a thickened part 7. As shown in fig. 4, the far infrared emission source 2 includes a transparent graphene electrothermal film and a temperature detector 4, the transparent graphene electrothermal film includes an insulating protective layer, 3 layers of graphene and an electrode disposed on the surface of the graphene, the electrode includes a first electrode 9 and a second electrode 10, and the temperature detector 4 has a probe, a first wiring pin and a second wiring pin. And a probe of the temperature detector is contacted with the transparent graphene electrothermal film. The first wiring pin of the temperature detector 4 is provided with a first conductive terminal 11, the second wiring pin of the temperature detector 4 is provided with a second conductive terminal 12, the first pole 9 of the electrode and the first wiring pin of the temperature detector 4 share the first conductive terminal 11, and the second pole 10 of the electrode is provided with a third conductive terminal 13. The first, second and third conductive terminals 11, 12 and 13 are connected to wires (wires are not shown) respectively, so as to be connected to a power source when in use.
Example 2
As shown in fig. 5, the therapeutic apparatus of the present embodiment comprises a controller 1, a treatment head 21 in the shape of a fan ring, a treatment head 22 and a treatment head 23, wherein the controller and the treatment head are connected through an elastic lead 8 made of a rubber composite carbon nanotube material. The treatment head 21, the treatment head 22 and the treatment head 23 are connected into a whole through the silica gel 3, and the far infrared emission source 2 which is the same as the embodiment 1 is arranged in each treatment head. The treatment heads 21, 22 and 23 are connected in parallel so that the controller can control the power of each treatment head separately.
Claims (9)
1. The far infrared mammary gland hyperplasia therapeutic apparatus is characterized by comprising a controller (1) and a therapeutic head group, wherein the controller (1) is connected with the therapeutic head group, the therapeutic head group comprises more than 1 therapeutic head, the therapeutic head comprises a heat conduction insulating layer (3), a far infrared emission source (2) and a bonding layer (5), the therapeutic head is in a fan-shaped ring shape, the far infrared emission source (2) is positioned inside the heat conduction insulating layer (3), the bonding layer (5) is positioned on the bottom surface of the therapeutic head, and the heat conduction insulating layer (3) is transparent silica gel;
the far infrared emission source (2) comprises a transparent graphene electrothermal film and a temperature detector (4), the transparent graphene electrothermal film comprises an insulation protective layer, graphene and an electrode arranged on the surface of the graphene, and a probe of the temperature detector (4) is in contact with the transparent graphene electrothermal film;
the temperature detector (4) comprises a first connection pin and a second connection pin, and the electrode comprises a first pole (9) and a second pole (10); a first wiring pin of the temperature detector (4) is connected with a first pole (9) of the electrode, and a second wiring pin of the temperature detector (4) is not connected with the electrode; the far infrared emission source (2) comprises a lead (8), the lead (8) comprises a first lead, a second lead and a third lead, the first lead is connected with a first wiring pin of the temperature detector (4) and/or a first pole (9) of the electrode, the second lead is connected with a second wiring pin of the temperature detector (4), and the third lead is connected with a second pole (10) of the electrode; the first wiring foot of temperature detector (4) sets up first conductive terminal (11), the second wiring foot of temperature detector (4) sets up second conductive terminal (12), the first utmost point (9) of electrode with first conductive terminal (11) are shared in temperature detector (4), the second utmost point (10) of electrode set up third conductive terminal (13), first wire is connected first conductive terminal (11), the second wire is connected second conductive terminal (12), the third wire is connected third conductive terminal (13).
2. The apparatus according to claim 1, wherein the therapy head group comprises more than 2 therapy heads which are independent or connected into a whole.
3. The therapeutic apparatus according to claim 1, wherein the number of graphene layers is 1-5.
4. An apparatus according to any one of claims 1-3, wherein the adhesive layer (5) is a hydrogel.
5. An apparatus according to any of claims 1-3, wherein the controller (1) has a built-in power supply.
6. The apparatus according to claim 5, wherein the power source is selected from lithium ion batteries.
7. An apparatus according to any of claims 1-3, wherein the controller (1) and the therapy head set are connected by an elastic lead.
8. The apparatus according to claim 7, wherein the flexible wire is selected from carbon nanotube composites.
9. An apparatus according to any of claims 1-3, wherein the controller (1) incorporates a cord reel.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911306481.8A CN110975163B (en) | 2019-12-18 | 2019-12-18 | Portable graphene far infrared mammary gland hyperplasia therapeutic apparatus |
| PCT/CN2020/133081 WO2021121025A1 (en) | 2019-12-18 | 2020-12-01 | Far-infrared emission source and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911306481.8A CN110975163B (en) | 2019-12-18 | 2019-12-18 | Portable graphene far infrared mammary gland hyperplasia therapeutic apparatus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110975163A CN110975163A (en) | 2020-04-10 |
| CN110975163B true CN110975163B (en) | 2022-03-15 |
Family
ID=70095098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911306481.8A Active CN110975163B (en) | 2019-12-18 | 2019-12-18 | Portable graphene far infrared mammary gland hyperplasia therapeutic apparatus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110975163B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021121028A1 (en) * | 2019-12-18 | 2021-06-24 | 成都石墨烯应用产业技术研究院有限公司 | Graphene far-infrared breast therapeutic instrument |
| WO2021121025A1 (en) * | 2019-12-18 | 2021-06-24 | 成都石墨烯应用产业技术研究院有限公司 | Far-infrared emission source and use thereof |
| CN114146308B (en) * | 2020-12-29 | 2022-11-04 | 江苏海莱新创医疗科技有限公司 | Temperature control device of electric field therapeutic apparatus and adjusting method thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105846776A (en) * | 2016-05-18 | 2016-08-10 | 济南圣泉集团股份有限公司 | Solar curtain |
| CN207184842U (en) * | 2017-09-11 | 2018-04-03 | 山东圣泉新材料股份有限公司 | A kind of graphene heating film, graphene composite bed and graphene heater |
| CN207734275U (en) * | 2017-05-31 | 2018-08-17 | 广州市一棵树网络科技有限公司 | A kind of graphene heating paste |
| CN208784129U (en) * | 2018-01-26 | 2019-04-26 | 上海华烯新材料科技有限公司 | A kind of graphene temperature control mattress |
| EP3514053A1 (en) * | 2018-01-19 | 2019-07-24 | Goodrich Corporation | Carbon nanotube heaters for aircraft heated floor panels |
| CN110475396A (en) * | 2019-09-12 | 2019-11-19 | 合肥微晶材料科技有限公司 | A kind of graphene fever membrane module with single side function far infrared radiation function and the warm bed treasured based on it |
| CN110505720A (en) * | 2019-09-19 | 2019-11-26 | 石家庄邦迪高分子材料有限公司 | A kind of graphene Far-infrared negative oxygen ion heating piece and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105901788A (en) * | 2016-04-28 | 2016-08-31 | 曾新民 | Method for manufacturing physiotherapeutic bra with movable thermal graphene gel pieces |
-
2019
- 2019-12-18 CN CN201911306481.8A patent/CN110975163B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105846776A (en) * | 2016-05-18 | 2016-08-10 | 济南圣泉集团股份有限公司 | Solar curtain |
| CN207734275U (en) * | 2017-05-31 | 2018-08-17 | 广州市一棵树网络科技有限公司 | A kind of graphene heating paste |
| CN207184842U (en) * | 2017-09-11 | 2018-04-03 | 山东圣泉新材料股份有限公司 | A kind of graphene heating film, graphene composite bed and graphene heater |
| EP3514053A1 (en) * | 2018-01-19 | 2019-07-24 | Goodrich Corporation | Carbon nanotube heaters for aircraft heated floor panels |
| CN208784129U (en) * | 2018-01-26 | 2019-04-26 | 上海华烯新材料科技有限公司 | A kind of graphene temperature control mattress |
| CN110475396A (en) * | 2019-09-12 | 2019-11-19 | 合肥微晶材料科技有限公司 | A kind of graphene fever membrane module with single side function far infrared radiation function and the warm bed treasured based on it |
| CN110505720A (en) * | 2019-09-19 | 2019-11-26 | 石家庄邦迪高分子材料有限公司 | A kind of graphene Far-infrared negative oxygen ion heating piece and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110975163A (en) | 2020-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110975163B (en) | Portable graphene far infrared mammary gland hyperplasia therapeutic apparatus | |
| CN107616911B (en) | Preparation method based on carbon nano composite flexible electrode and miniature intelligent acupuncture physiotherapy instrument | |
| CN106137518B (en) | Light and thin heating neck guard | |
| CN107536669B (en) | Wearing physiotherapy equipment based on liquid metal | |
| TW201731555A (en) | Transcutaneous nerve stimulation device having optoelectronic thermotherapy function and signal control method thereof by combining optoelectronic thermotherapy function with automatic control to achieve the purpose of enhancing the transcutaneous nerve stimulation effect | |
| CN110652653A (en) | Electrical stimulation hair growth system | |
| CN211128236U (en) | Far infrared emission source and far infrared electric heating paster | |
| CN207270569U (en) | A kind of multifunction wireless controls lumbar vertebrae diseases therapeutic equipment | |
| WO2021128980A1 (en) | Electrode assembly for electrical stimulation massage device, and electrical stimulation massage device for cervical vertebrae | |
| CN111888619B (en) | Wearable cervical vertebra rehabilitation sleep instrument | |
| CN208541691U (en) | Intelligent miniature acupuncture and moxibustion physiotherapeutic instrument based on the nano combined flexible electrode of carbon | |
| WO2021121025A1 (en) | Far-infrared emission source and use thereof | |
| CN106730358B (en) | Portable electromagnetic field effect treatment subsides | |
| WO2021121028A1 (en) | Graphene far-infrared breast therapeutic instrument | |
| CN111084937A (en) | Portable ultrasonic low-intermediate frequency conductivity therapeutic instrument | |
| CN219231230U (en) | Pulse electromagnetic mammary gland therapeutic instrument and charging box | |
| CN112999521A (en) | Graphene far infrared mammary gland therapeutic apparatus | |
| US20070276456A1 (en) | Band for Curing Human Body | |
| CN207950336U (en) | A kind of magnetic connects flexibility physiogherapy electrode plate and electrode sheet devices | |
| CN206687725U (en) | A kind of Cardiological stethoscope of temperature controllable | |
| CN211724420U (en) | Portable ultrasonic low-intermediate frequency conductivity therapeutic instrument | |
| CN213489698U (en) | Wearable cervical vertebra rehabilitation sleep instrument | |
| TWM525754U (en) | Transcutaneous electronic nerve stimulation having photo-thermoelectric therapy function | |
| CN208626426U (en) | A kind of adjustable constant-temp fever electrode | |
| CN215229078U (en) | Cervical vertebra massager and cervical vertebra massage system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |